FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016799495> ?p ?o ?g. }

• W2016799495 endingPage "456" @default.
• W2016799495 startingPage "447" @default.
• W2016799495 abstract "Interleukin 1 alpha (IL-1) is a polypeptide/glycoprotein growth factor with multiple functions including the modulation of hematopoietic cell proliferation and differentiation. In vivo studies were performedwith C57BL/6J mice injected with 0, 0.2, or 2.0 μg of IL-1 24 hr before or after lethal total body irradiation (TBI) (9.5 Gy). More mice in the groups administered IL-1 before TBI survived (90% of the 2.0 μg group) than those treated 2 or 24 hr after TBI, which was still slightly superior to the uninjected group, which all died within 15 days (p = .0001). Proliferation of bone marrow granulocyte/macrophage colonies following split dose TBI was also greatest for mouse groups treated with IL-1 prior to TBI. These experiments support data from other investigators that IL-1 stimulation of BM is related to IL-I timing with respect to TBI. Stimulation of hemopoiesis was also assessed in terms of changes in peripheral blood and BM cell numbers and cell cycle kinetics using an electronic particle counter and flow cytometric techniques. Mice injected with 2 μg of IL-1 showed an initial decline (at 3–6 hr) and then a selective proliferation (24–48 hr) of early and more committed progenitor cells to 125% and 200° of control values, respectively. Peripheral blood counts rose accordingly. Cells in S and G2/M phases increased over 10 hr and then declined in number. It thus appeared that some synchronization of cell cycling occurred, which might place cells in a more radioresistant phase of the cell cycle. The glutathione (GSH) content and synthesis in BM cells were measured by isocratic paired-ion high performance liquid chromatography and 35S-labelled cysteine incorporation into the GSH tripeptide. An increase in cellular GSH content and synthesis was demonstrated following IL-1 which lasted 24 hr, suggesting a possible mechanism for the radioprotection by IL-1. To determine the potential for achieving a favorable therapeutic ratio, KHT tumor-bearing mice were injected with 2.0 μg IL-1. No change in tumor diameters or weights or tumor cell clonogenicity between IL-1 treated or untreated animals was observed. These experiments strongly support a role for IL-1 in stimulating bone marrow to overcome the myelosuppressive effects of irradiation." @default.
• W2016799495 created "2016-06-24" @default.
• W2016799495 creator A5001008875 @default.
• W2016799495 creator A5002120651 @default.
• W2016799495 creator A5024834771 @default.
• W2016799495 creator A5041021400 @default.
• W2016799495 creator A5047898005 @default.
• W2016799495 creator A5050528926 @default.
• W2016799495 date "1991-03-01" @default.
• W2016799495 modified "2023-09-27" @default.
• W2016799495 title "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation" @default.
• W2016799495 cites W1486523175 @default.
• W2016799495 cites W1488986146 @default.
• W2016799495 cites W1499511373 @default.
• W2016799495 cites W1575925035 @default.
• W2016799495 cites W1594253455 @default.
• W2016799495 cites W1595702103 @default.
• W2016799495 cites W1963180296 @default.
• W2016799495 cites W1983232483 @default.
• W2016799495 cites W1986396520 @default.
• W2016799495 cites W1991367605 @default.
• W2016799495 cites W2009156957 @default.
• W2016799495 cites W2028651992 @default.
• W2016799495 cites W2037139757 @default.
• W2016799495 cites W2038071596 @default.
• W2016799495 cites W2041254296 @default.
• W2016799495 cites W2052264823 @default.
• W2016799495 cites W2066804997 @default.
• W2016799495 cites W2098450145 @default.
• W2016799495 cites W2120895054 @default.
• W2016799495 cites W2132447807 @default.
• W2016799495 cites W2168514322 @default.
• W2016799495 cites W2410399325 @default.
• W2016799495 cites W2412134447 @default.
• W2016799495 cites W2437562009 @default.
• W2016799495 cites W270079318 @default.
• W2016799495 cites W305838808 @default.
• W2016799495 cites W313927096 @default.
• W2016799495 cites W4298178708 @default.
• W2016799495 doi "https://doi.org/10.1016/0360-3016(91)90056-a" @default.
• W2016799495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1995530" @default.
• W2016799495 hasPublicationYear "1991" @default.
• W2016799495 type Work @default.
• W2016799495 sameAs 2016799495 @default.
• W2016799495 citedByCount "18" @default.
• W2016799495 countsByYear W20167994952013 @default.
• W2016799495 countsByYear W20167994952014 @default.
• W2016799495 countsByYear W20167994952015 @default.
• W2016799495 crossrefType "journal-article" @default.
• W2016799495 hasAuthorship W2016799495A5001008875 @default.
• W2016799495 hasAuthorship W2016799495A5002120651 @default.
• W2016799495 hasAuthorship W2016799495A5024834771 @default.
• W2016799495 hasAuthorship W2016799495A5041021400 @default.
• W2016799495 hasAuthorship W2016799495A5047898005 @default.
• W2016799495 hasAuthorship W2016799495A5050528926 @default.
• W2016799495 hasBestOaLocation W20167994951 @default.
• W2016799495 hasConcept C109159458 @default.
• W2016799495 hasConcept C126322002 @default.
• W2016799495 hasConcept C134018914 @default.
• W2016799495 hasConcept C16685009 @default.
• W2016799495 hasConcept C201750760 @default.
• W2016799495 hasConcept C203014093 @default.
• W2016799495 hasConcept C24998067 @default.
• W2016799495 hasConcept C2776694085 @default.
• W2016799495 hasConcept C2776755627 @default.
• W2016799495 hasConcept C2778690821 @default.
• W2016799495 hasConcept C2778880498 @default.
• W2016799495 hasConcept C2780007613 @default.
• W2016799495 hasConcept C28328180 @default.
• W2016799495 hasConcept C71924100 @default.
• W2016799495 hasConcept C74172505 @default.
• W2016799495 hasConcept C86803240 @default.
• W2016799495 hasConcept C95444343 @default.
• W2016799495 hasConceptScore W2016799495C109159458 @default.
• W2016799495 hasConceptScore W2016799495C126322002 @default.
• W2016799495 hasConceptScore W2016799495C134018914 @default.
• W2016799495 hasConceptScore W2016799495C16685009 @default.
• W2016799495 hasConceptScore W2016799495C201750760 @default.
• W2016799495 hasConceptScore W2016799495C203014093 @default.
• W2016799495 hasConceptScore W2016799495C24998067 @default.
• W2016799495 hasConceptScore W2016799495C2776694085 @default.
• W2016799495 hasConceptScore W2016799495C2776755627 @default.
• W2016799495 hasConceptScore W2016799495C2778690821 @default.
• W2016799495 hasConceptScore W2016799495C2778880498 @default.
• W2016799495 hasConceptScore W2016799495C2780007613 @default.
• W2016799495 hasConceptScore W2016799495C28328180 @default.
• W2016799495 hasConceptScore W2016799495C71924100 @default.
• W2016799495 hasConceptScore W2016799495C74172505 @default.
• W2016799495 hasConceptScore W2016799495C86803240 @default.
• W2016799495 hasConceptScore W2016799495C95444343 @default.
• W2016799495 hasIssue "3" @default.
• W2016799495 hasLocation W20167994951 @default.
• W2016799495 hasLocation W20167994952 @default.
• W2016799495 hasOpenAccess W2016799495 @default.
• W2016799495 hasPrimaryLocation W20167994951 @default.
• W2016799495 hasRelatedWork W1978598034 @default.
• W2016799495 hasRelatedWork W1984619393 @default.
• W2016799495 hasRelatedWork W2012205823 @default.

• next